Report Overview

Rising burden of blood disorders, increasing advancements in bone marrow transplantation techniques, growing awareness about bone marrow transplantation options, and government initiatives are expected to drive the India Bone Marrow Transplantation Market during the forecast period between 2024 and 2030.

India Bone Marrow Transplantation Market – Industry Trends & Forecast Report, 2030

India Bone Marrow Transplantation Market size was estimated at USD 0.783 billion in 2023. During the forecast period between 2024 and 2030, the India Bone Marrow Transplantation Market size is projected to grow at a CAGR of 7.39% reaching a value of USD 1.29 billion by 2030. A prominent driver of the market is an increasing prevalence of cancer therapies. Notably, the rising acceptance of bone marrow transplantation and the surge in cases of anemia are crucial factors propelling market growth. The rapid progression of technology in these procedures emerges as a prominent trend in the bone marrow transplantation market, positively influencing its overall industry share. Also, the utilization of bone marrow transplant procedures is recommended to address advanced stages of various conditions, such as leukemia, Hodgkin and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia, and similar diseases. The expansion of the market in India is primarily attributed to heightened awareness and a surge in healthcare practitioner-led initiatives. Consequently, these factors are expected to bolster the growth of the India Bone Marrow Transplantation Market during the period in analysis.

Bone Marrow Transplantation – Overview

Bone marrow constitutes the pliable vascular tissue located within the elongated bones, primarily responsible for fostering the generation of blood cells, lymphocyte proliferation, and the accumulation of fat. Conditions such as advanced stages of leukemia, Hodgkin and non-Hodgkin Lymphomas, palatial, sickle cell anemia, thalassemia, among others, warrant consideration for bone marrow transplantation. The global count of bone marrow transplants surpassed 75,000 in 2015, with an anticipated growth of 25% by the conclusion of 2020. The transplantation process is alternatively referred to as peripheral stem cell transplantation (PSCT) or conventional bone marrow transplantation, depending on whether the bone marrow or stem cells serve as the primary source. The heightened demand for Bone Marrow Transplants (BMOs) and ongoing research endeavors aimed at mitigating the potential adverse effects of BMO transplantation could herald a new pinnacle in the market, offering enhanced healthcare prospects for millions across the globe.

India Bone Marrow Transplantation Market

Growth Drivers

Advancements in Bone Marrow Transplantation Techniques

The bone marrow transplantation market in India has witnessed significant advancements in transplantation techniques, particularly for critical conditions such as leukemia, lymphoma, multiple myeloma, aplastic anemia, and thalassemia. These advancements include refined stem cell harvesting and the use of peripheral blood stem cell (PBSC) transplantation. The expansion of India's bone marrow transplantation market is driven by proactive healthcare initiatives and increased awareness, with haploidentical transplantation broadening donor options. Improved conditioning regimens, including reduced-intensity conditioning (RIC), have extended transplant eligibility, especially for older patients. Infection prevention, graft-versus-host disease (GVHD) management, and next-generation sequencing have further enhanced outcomes. High-resolution HLA typing, expanded donor databases, cord blood transplantation, interdisciplinary collaborations, and ongoing research in immunotherapy and gene therapy exemplify India's commitment to advancing bone marrow transplantation. Cost-effective initiatives increase accessibility, ensuring that more patients can benefit from these innovative treatments. Overall, bone marrow transplantation has emerged as a pivotal and transformative solution in India's healthcare landscape.

Government’s Supportive Initiatives

The Indian government’s initiatives are playing a pivotal role in making bone marrow transplants accessible to those in need. The Central Government Health Schemes have partnered with renowned hospitals, such as Kokilaben Dhirubhai Ambani Hospital, AIIMS New Delhi, and Tata Medical Centre in Kolkata, to cover the expenses of bone marrow transplants for underprivileged children below 18 years. Additionally, the Ayushman Bharat Yojana offers coverage for bone marrow transplants to eligible beneficiaries, providing financial protection and healthcare benefits to economically vulnerable individuals. These initiatives are addressing the financial constraints associated with bone marrow transplants, ensuring that individuals, especially children and those suffering from severe conditions, can avail themselves of this life-saving medical procedure.

Rising Burden of Blood Disorders

The surging incidence of blood disorders, particularly blood cancer, presents a growing healthcare challenge in India. The country, ranking third globally in reported cases, witnesses a concerning frequency of a blood cancer diagnosis every 5 minutes, leading to an estimated 70,000 annual fatalities. Predominantly comprising leukemia, lymphoma, and myeloma, with leukemia alone accounting for over half of all cases, the escalating burden underscores a critical healthcare concern. In response, the India Bone Marrow Transplantation Market is gaining prominence. The heightened prevalence of blood disorders is amplifying the demand for bone marrow transplantation as a crucial treatment avenue, thereby propelling the market's growth.

Challenges

High Treatment Costs

The growth of the India Bone Marrow Transplants Market faces constraints due to prohibitively high treatment costs. With expenses ranging INR 4–28 lakhs, a sizeable portion of the population, approximately 90–95%, finds the treatment financially out of reach. The economic barrier impedes market expansion, highlighting the need for strategic interventions to make Bone Marrow Transplants more affordable and accessible to a broader demographic in the country.

Impact of Escalating Geopolitical Tensions on India Bone Marrow Transplantation Market

The India Bone Marrow Transplantation Market faces potential challenges due to escalating geopolitical tensions. These tensions may impact the supply chain, hindering the availability of essential medical resources and creating uncertainties in healthcare infrastructure. The collaboration between international organizations and Indian healthcare facilities, crucial for advanced treatments like bone marrow transplantation, could be affected. Additionally, geopolitical unrest might contribute to economic uncertainties, potentially affecting funding for medical research and accessibility to innovative treatments. Adapting to these challenges will be vital for sustaining the growth and effectiveness of the Bone Marrow Transplantation Market in India amid an evolving geopolitical landscape.

India Bone Marrow Transplantation Market

Segmental Coverage

India Bone Marrow Transplantation Market – By Type

By type, the India Bone Marrow Transplantation Market is bifurcated into Allogeneic Bone Marrow Transplant and Autologous Bone Marrow Transplant segments. The autologous bone marrow transplant segment is expected to hold a higher share in the India Bone Marrow Transplantation Market by type during the forecast period. It is primarily due to its application in treating various cancers. Autologous transplants involve using the patient's own bone marrow or stem cells, reducing the risk of graft-versus-host disease. This method is commonly employed in the treatment of hematological malignancies like lymphoma and myeloma. The relative simplicity and decreased likelihood of immune complications contribute to the prominence of autologous bone marrow transplantation, making it a preferred choice in the therapeutic landscape for specific cancer types.

India Bone Marrow Transplantation Market – By Disease Indication

Based on disease indication, the India Bone Marrow Transplantation Market is divided into Leukemia, Lymphoma, Myeloma, Anemia, and other (including Myeloproliferative Disorders and Thalassemia) segments. The lymphoma segment holds the highest share in the India Bone Marrow Transplantation Market by disease indication. It can be attributed to the prevalence of hematological malignancies, particularly lymphomas, in the country. Lymphomas often require intensive treatment, and bone marrow transplantation serves as a crucial therapeutic option, especially for refractory or relapsed cases. The effectiveness of transplant procedures in treating lymphomas, coupled with advancements in transplantation techniques, contributes to the higher market share. The rising incidence of lymphomas and the successful outcomes of bone marrow transplants in this context further underscore the segment's significance in the market.

India Bone Marrow Transplantation Market – By End User

On the basis of end user, the India Bone Marrow Transplantation Market is divided into Hospitals, Clinics, and Ambulatory Surgical Center segments. The hospitals segment holds the highest share in the India Bone Marrow Transplantation Market by end user. The hospital segment is bolstered by state-of-the-art medical infrastructure, a cadre of skilled healthcare professionals, and the escalating incidence of cancer and anemia. This segment finds support due to the imperative role of bone marrow transplants in addressing advanced stages of blood cancer, sickle cell anemia, and various chronic disorders.

India Bone Marrow Transplantation Market – By Region

Geographically, the India Bone Marrow Transplantation Market is divided into North India, South India, East India, and West India regions.

Competitive Landscape

Major players operating in India Bone Marrow Transplantation Market include Lonza, Qiagen N.V., Diadexus Inc, MDR India, DATRI, Charles River Laboratories, and ReeLabs Pvt Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In January 2024 - Fortis Healthcare inaugurated a cutting-edge facility dedicated to the specialized treatment of blood cancers and disorders, addressing the pressing need for holistic care. The Fortis Institute of Blood Disorders combines pediatric and geriatric care, advanced transplant procedures, and hematopathology expertise, offering comprehensive services. The institute introduced CAR-T cell therapy across its Bone Marrow Transplant centers in Mohali, Delhi, Gurgaon, Noida, Mumbai, and Bangalore. Supported by a collaboration with ImmunoACT, the initiative introduces NexCAR19, India's first market-authorized CAR-T cell therapy, providing a breakthrough in treating challenging blood cancers.

• In November 2023 - The Army Hospital (Research And Referral) in Delhi Cantonment performed its first life-saving Bone Marrow Transplant (BMT) on 7-year-old Master Sushant Paudel. Diagnosed with the rare primary immunodeficiency disorder ARPC1b at the age of one, Sushant faced repeated life-threatening infections. Despite lacking an HLA-matched sibling donor, the hospital's Hematology team orchestrated a Matched Unrelated Donor (MUD) transplant, securing stem cells from a voluntary unrelated donor. The meticulous procedure aimed to replace Sushant's compromised immune cells, offering renewed hope for a healthy life.

Scope of the Report

By Type

• Allogeneic Bone Marrow Transplant

• Autologous Bone Marrow Transplant

By Disease Indication

• Leukemia

• Lymphoma

• Myeloma

• Anemia

By End User

• Hospitals

• Clinics

• Ambulatory Surgical Center

By Region

• North India

• South India

• East India

• West India